VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants

Virus-like particles (VLPs) are a versatile, safe, and highly immunogenic vaccine platform. Recently, there are developmental vaccines targeting SARS-CoV-2, the causative agent of COVID-19. The COVID-19 pandemic affected humanity worldwide, bringing out incomputable human and financial losses. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Prates-Syed, Wasim A., Chaves, Lorena C. S., Crema, Karin P., Vuitika, Larissa, Lira, Aline, Côrtes, Nelson, Kersten, Victor, Guimarães, Francisco E. G., Sadraeian, Mohammad, Barroso da Silva, Fernando L., Cabral-Marques, Otávio, Barbuto, José A. M., Russo, Momtchilo, Câmara, Niels O. S., Cabral-Miranda, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708688/
https://www.ncbi.nlm.nih.gov/pubmed/34960155
http://dx.doi.org/10.3390/vaccines9121409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708688/
https://www.ncbi.nlm.nih.gov/pubmed/34960155
http://dx.doi.org/10.3390/vaccines9121409

Ejemplares similares